Skip to main content
. 2015 Dec 9;42(3):814–823. doi: 10.1093/schbul/sbv179

Fig. 4.

Fig. 4.

PTPRD rs10977144 genotype (TT+CT vs CC carriers) modulated BMI gain (kg/m2) over 8 weeks of risperidone and quetiapine treatment in the 236 first-episode, drug-naive schizophrenia patients. Considering number of TT carriers was only 3, we combined TT and CT carriers in one group. *P < .05; **P < .0001.